BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walters MD, Levin M, Smith C, Nokes TJ, Hardisty RM, Dillon MJ, Barratt TM. Intravascular platelet activation in the hemolytic uremic syndrome. Kidney International 1988;33:107-15. [DOI: 10.1038/ki.1988.17] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney Int. 1998;54:1324-1330. [PMID: 9767551 DOI: 10.1046/j.1523-1755.1998.00103.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
2 Robson WL, Leung AK, Kaplan BS. Hemolytic-uremic syndrome. Curr Probl Pediatr 1993;23:16-33. [PMID: 8453889 DOI: 10.1016/0045-9380(93)90027-a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fernandez GC, Gomez SA, Ramos MV, Bentancor LV, Fernandez-brando RJ, Landoni VI, Lopez L, Ramirez F, Diaz M, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS. The Functional State of Neutrophils Correlates With the Severity of Renal Dysfunction in Children With Hemolytic Uremic Syndrome. Pediatr Res 2007;61:123-8. [DOI: 10.1203/01.pdr.0000250037.47169.55] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
4 Beattie TJ. Recent developments in the pathogenesis of hemolytic uremic syndrome. Ren Fail 1990;12:3-7. [PMID: 2236721 DOI: 10.3109/08860229009066958] [Reference Citation Analysis]
5 Karch H, Bitzan M, Pietsch R, Stenger K, von Wulffen H, Heesemann J, Düsing R. Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. Microbial Pathogenesis 1988;5:215-21. [DOI: 10.1016/0882-4010(88)90024-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
6 Taylor CM, Lote CJ. Prostacyclin in diarrhoea-associated haemolytic uraemic syndrome. Pediatr Nephrol 1993;7:515-9. [DOI: 10.1007/bf00852530] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
7 Sanger GJ, Twycross R. Making Sense of Emesis, Pruritus, 5-HT and 5-HT 3 Receptor Antagonists. Progress in Palliative Care 2016;4:7-8. [DOI: 10.1080/09699260.1996.11746729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Russo P, Doyon J, Sonsino E, Ogier H, Saudubray J. A congenital anomaly of vitamin B12 metabolism: A study of three cases. Human Pathology 1992;23:504-12. [DOI: 10.1016/0046-8177(92)90127-o] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
9 Zeigler ZR, Rosenfeld CS, Andrews DF, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 1996;53:213-20. [DOI: 10.1002/(sici)1096-8652(199612)53:4<213::aid-ajh1>3.0.co;2-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
10 Bergstein JM. Glomerular fibrin deposition and removal. Pediatr Nephrol 1990;4:78-87. [PMID: 2206888 DOI: 10.1007/BF00858447] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
11 Rippe B, Krediet RT. Peritoneal physiology-transport of solutes. In: Gokal R, Nolph KD, editors. The Textbook of Peritoneal Dialysis. Dordrecht: Springer Netherlands; 1994. pp. 69-113. [DOI: 10.1007/978-94-011-0814-0_4] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 2.3] [Reference Citation Analysis]
12 Karpman D, Ståhl AL. Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response. Microbiol Spectr 2014;2. [PMID: 26104359 DOI: 10.1128/microbiolspec.EHEC-0009-2013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
13 Fizpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt TM. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. The Journal of Pediatrics 1993;122:532-7. [DOI: 10.1016/s0022-3476(05)83531-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
14 van de Kar N, Monnens L. 15 The haemolytic-uraemic syndrome in childhood. Baillière's Clinical Haematology 1998;11:497-507. [DOI: 10.1016/s0950-3536(98)80063-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
15 Gomez SA, Abrey-Recalde MJ, Panek CA, Ferrarotti NF, Repetto MG, Mejías MP, Fernández GC, Vanzulli S, Isturiz MA, Palermo MS. The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome. Clin Exp Immunol 2013;173:463-72. [PMID: 23607458 DOI: 10.1111/cei.12124] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
16 Karpman D, Papadopoulou D, Nilsson K, Sjögren AC, Mikaelsson C, Lethagen S. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 2001;97:3100-8. [PMID: 11342436 DOI: 10.1182/blood.v97.10.3100] [Cited by in Crossref: 100] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
17 Tönshoff B, Momper R, Kühl PG, Schweer H, Schärer K, Seyberth HW. Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney International 1990;37:1134-41. [DOI: 10.1038/ki.1990.96] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
18 Winchester JF, Lindsay RM. Bleeding disorders in renal failure. In: Hörl WH, Koch KM, Lindsay RM, Ronco C, Winchester JF, editors. Replacement of Renal Function by Dialysis. Dordrecht: Springer Netherlands; 2004. pp. 919-25. [DOI: 10.1007/978-1-4020-2275-3_38] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Glynne P, Salama A, Chaudhry A, Swirsky D, Lightstone L. Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome. Am J Kidney Dis 1999;33:133-7. [PMID: 9915279 DOI: 10.1016/s0272-6386(99)70269-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
20 Benigni A, Boccardo P, Noris M, Remuzzi G, Siegler R. Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome. The Lancet 1992;339:835-6. [DOI: 10.1016/0140-6736(92)90281-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
21 Constantinescu AR, Bitzan M, Weiss LS, Christen E, Kaplan BS, Cnaan A, Trachtman H. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis 2004;43:976-82. [PMID: 15168377 DOI: 10.1053/j.ajkd.2004.02.010] [Cited by in Crossref: 142] [Cited by in F6Publishing: 107] [Article Influence: 8.4] [Reference Citation Analysis]
22 Viisoreanu D, Polanowska-Grabowska R, Suttitanamongkol S, Obrig TG, Gear AR. Human platelet aggregation is not altered by Shiga toxins 1 or 2. Thromb Res 2000;98:403-10. [PMID: 10828480 DOI: 10.1016/s0049-3848(00)00191-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
23 Renaud C, Niaudet P, Gagnadoux MF, Broyer M, Habib R. Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age. Pediatr Nephrol 1995;9:24-9. [PMID: 7742216 DOI: 10.1007/BF00858960] [Cited by in Crossref: 29] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
24 Rahman M, Hossain M. The Bimodal Mortality Pattern of Acute Renal Failure in Children. Renal Failure 2009;15:55-9. [DOI: 10.3109/08860229309065573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
25 Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Kongkhum S, Heatherly D, Obrig T, Gear AR. Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun 2005;73:8306-16. [PMID: 16299328 DOI: 10.1128/IAI.73.12.8306-8316.2005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
26 Rahman M, Hossain M. Acute Renal Failure in Asia. In: Hatano M, editor. Nephrology. Berlin: Springer Berlin Heidelberg; 1991. pp. 804-14. [DOI: 10.1007/978-3-662-35158-1_78] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
27 Siegler RL. The Hemolytic Uremic Syndrome. Pediatric Clinics of North America 1995;42:1505-29. [DOI: 10.1016/s0031-3955(16)40096-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
28 Noris M, Benigni A, Siegler R, Gaspari F, Casiraghi F, Mancini ML, Remuzzi G. Renal Prostacyclin Biosynthesis Is Reduced in Children With Hemolytic-Uremic Syndrome in the Context of Systemic Platelet Activation. American Journal of Kidney Diseases 1992;20:144-9. [DOI: 10.1016/s0272-6386(12)80542-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
29 Dran GI, Fernández GC, Rubel CJ, Bermejo E, Gomez S, Meiss R, Isturiz MA, Palermo MS. Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Kidney Int 2002;62:1338-48. [PMID: 12234304 DOI: 10.1111/j.1523-1755.2002.kid554.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
30 Naqvi R. Hemolytic Uremic syndrome associated with pregnancy: Outcome from acute Kidney Injury. Pak J Med Sci 2020;36:1153-7. [PMID: 32968372 DOI: 10.12669/pjms.36.6.2931] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Proulx F, Seidman EG, Karpman D. Pathogenesis of Shiga Toxin-Associated Hemolytic Uremic Syndrome. Pediatr Res 2001;50:163-71. [DOI: 10.1203/00006450-200108000-00002] [Cited by in Crossref: 139] [Cited by in F6Publishing: 126] [Article Influence: 6.6] [Reference Citation Analysis]
32 Robson WL. Haemolytic uraemic syndrome. Paediatr Drugs 2000;2:243-52. [PMID: 10946413 DOI: 10.2165/00128072-200002040-00001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
33 Hoffman M, Monroe DM, Roberts HR. Platelet activation in patients with thrombotic thrombocytopenic purpura. Am J Hematol 1993;42:182-5. [DOI: 10.1002/ajh.2830420208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
34 Ghosh SA, Polanowska-Grabowska RK, Fujii J, Obrig T, Gear AR. Shiga toxin binds to activated platelets. J Thromb Haemost 2004;2:499-506. [PMID: 15009469 DOI: 10.1111/j.1538-7933.2004.00638.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
35 Holloway S, Senior D, Roth L, Tisher CC. Hemolytic Uremic Syndrome in Dogs. Journal of Veterinary Internal Medicine 1993;7:220-7. [DOI: 10.1111/j.1939-1676.1993.tb01011.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
36 Sens YAS, Miorin LA, Silva HGC, Malheiros DM, Filho DM, Jabur P. Acute Renal Failure Due to Hemolytic Uremic Syndrome in Adult Patients. Renal Failure 2009;19:279-82. [DOI: 10.3109/08860229709026289] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
37 H�bert D, Kim E, Sibley RK, Mauer MS. Post-transplantation outcome of patients with hemolytic-uremic syndrome: update. Pediatr Nephrol 1991;5:162-7. [DOI: 10.1007/bf00852876] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Neild GH. Haemolytic-uraemic syndrome in practice. Lancet 1994;343:398-401. [PMID: 7905557 DOI: 10.1016/s0140-6736(94)91228-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]